Effect of antimicrobial therapy on progression free survival of immunotherapy and chemo-/ immunotherapy in patients with NSCLC.

被引：0
|
作者：
Uhlenbruch, M. [1 ]
Krueger, S. [1 ]
机构：
[1] Florence Nightingale Krankenhaus Dusseldorf, Klin Pneumol Kardiol Internist Intensivmed, Dusseldorf, Germany
来源：
PNEUMOLOGIE | 2024年 / 78卷
关键词：
D O I：
10.1055/s-0044-1778946
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV 27
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [41] Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival
    Turturro, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (07) : 959 - 965
  • [42] Effect of Early Steroids use in Advanced NSCLC Patients Treated with Immunotherapy
    Fuca, G.
    Poggi, M.
    Galli, G.
    Imbimbo, M.
    Lo Russo, G.
    Proto, C.
    Vitali, M.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Signorelli, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S390 - S390
  • [43] Molecular remission is an independent predictor of progression-free survival in patients with Waldenstrom macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study
    Varettoni, Marzia
    Zibellini, Silvia
    Merli, Michele
    Drandi, Daniela
    Jimenez, Cristina
    Furlan, Daniela
    Ferretti, Virginia Valeria
    Fabbri, Nicole
    Dogliotti, Irene
    Varraso, Chiara
    Ferrante, Martina
    Cappello, Emilia
    Peri, Veronica
    Cavalloni, Chiara
    Borriero, Michela
    Facchetti, Giulia Vittoria
    Ferrero, Simone
    Arcaini, Luca
    Garcia-Sanz, Ramon
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (03) : 574 - 577
  • [44] Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
    Cui, Jiuwei
    Wang, Nanya
    Zhao, Hengjun
    Jin, Haofan
    Wang, Guanjun
    Niu, Chao
    Terunuma, Hiroshi
    He, Hua
    Li, Wei
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (02) : 342 - 351
  • [45] Is RECIST-defined progression free-survival a meaningful endpoint in the era of immunotherapy?
    Johal, Sukhvinder
    Santi, Irene
    Doan, Justin
    George, Saby
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [46] PROGRESSION-FREE SURVIVAL IS A ROBUST SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF HEPATOCELLULAR CARCINOMA
    Cabibbo, Giuseppe
    Celsa, Ciro
    Enea, Marco
    Battaglia, Salvatore
    Rizzo, Giacomo
    Busacca, Anita
    Matranga, Domenica
    Attanasio, Massimo
    Reig, Maria
    Craxi, Antonio
    Camma, Calogero
    HEPATOLOGY, 2020, 72 : 649A - 649A
  • [47] Long term Survival Outcomes in NSCLC Patients with Targeted Therapy and Immunotherapy: An IASLC Analysis of ASCO CancerLinQ Discovery Data
    Behera, M.
    Joseph, G.
    Rupji, M.
    Huang, Z.
    Bunn, B.
    Wynes, M.
    Switchenko, J.
    Scagliotti, G.
    Higgins, K.
    Tsao, M.
    Belani, C.
    Sequist, L.
    Ramalingam, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S368 - S369
  • [48] Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma
    Celsa, C.
    Cabibbo, G.
    Enea, M.
    Battaglia, S.
    Rizzo, G. E. M.
    Busacca, A.
    Matranga, D.
    Attanasio, M.
    Reig, M.
    Craxi, A.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S35 - S35
  • [49] The Role of a Cachexia Grading System in Patients with NSCLC Treated with Immunotherapy: Implications for Response and Survival
    Turcott, J.
    Cardona, A. F.
    Ramirez-Tirado, L.
    Zatarain Barron, Z. L.
    Barron, F.
    Corrales, L.
    Martin, C.
    Barragan Castillo, P. A.
    Flores-Estrada, D.
    Ruiz-Patino, A.
    Arrieta, O. G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S275 - S275
  • [50] DELTA-RADIOMICS SIGNATURE FOR PREDICTION OF SURVIVAL IN ADVANCED NSCLC PATIENTS TREATED WITH IMMUNOTHERAPY
    Farina, B.
    Ramos Guerra, A. D.
    Palacios Miras, C.
    Gallardo Madueno, G.
    Munoz-Barrutia, Arrate
    Peces-Barba, G. R.
    Seijo Maceiras, L.
    Corral, J.
    Gil-Bazo, I
    Domine Gomez, M.
    Ledesma-Carbayo, M. J.
    2021 IEEE 18TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2021, : 886 - 890
12345